DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
Teradata Corp
TDC
Collegium Pharmaceutical
COLL
Halozyme Therapeutics
HALO
Hutchmed (China)
HCM
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 79.17%159.54M | 53.94%117.83M | 56.76%127.09M | 28.48%350.97M | 15.95%104.31M | 48.25%89.05M | 87.06%76.54M | -1.41%81.07M | 14.43%273.17M | -5.48%89.97M |
Net income from continuing operations | 327.73%8.15M | 87.11%-14.44M | 116.23%5.93M | -56.36%-176.3M | -54.74%-24.2M | 88.61%-3.58M | -98.64%-111.96M | -291.45%-36.57M | -44.85%-112.75M | 4.49%-15.64M |
Operating gains losses | -100.95%-2.53M | -1,620.76%-3.59M | -4,317.60%-15.82M | 89.31%-341K | 96.41%1.04M | 16.13%-1.26M | -81.82%236K | 89.82%-358K | -445.72%-3.19M | -31.03%529K |
Depreciation and amortization | 21.94%25.01M | 35.15%22.2M | 28.15%21.23M | 24.98%72.67M | 23.45%19.17M | 31.79%20.51M | 15.17%16.43M | 29.47%16.57M | 28.77%58.15M | 29.69%15.53M |
Deferred tax | -382.98%-399K | -100.95%-45K | -455.32%-167K | 345.43%5.21M | 117.29%265K | 173.82%141K | 3,228.29%4.76M | 119.11%47K | 26.04%-2.12M | 0.97%-1.53M |
Other non cash items | -19.89%-13.12M | -119.12%-10.02M | -130.08%-12.06M | 470.75%26.34M | -84.40%-9.86M | -316.72%-10.94M | 23,381.78%52.38M | -580.13%-5.24M | -143.16%-7.11M | -212.50%-5.35M |
Change In working capital | 152.12%12.16M | 56.67%-5.77M | -43.91%13.23M | -118.11%-10.59M | -82.11%2.47M | -391.17%-23.34M | -1,529.00%-13.3M | -34.01%23.58M | -46.60%58.48M | -72.24%13.8M |
-Change in receivables | 46.01%-4.56M | 22.12%-7M | -16.96%25.42M | 22.12%-57.62M | -31.47%-70.8M | -46.01%-8.45M | 49.78%-8.99M | 761.91%30.62M | -116.92%-73.99M | -69.03%-53.85M |
-Change in prepaid assets | 63.04%18.62M | 19.51%-21.76M | 73.19%-5.47M | -685.84%-47.05M | -483.34%-11.03M | -12.46%11.42M | -50.29%-27.03M | -419.91%-20.42M | -455.90%-5.99M | -52.64%2.88M |
-Change in payables and accrued expense | 6,417.59%25.94M | 22.13%29.41M | -414.86%-14.58M | 44.21%73.04M | 86.65%43.93M | 108.07%398K | 13.12%24.08M | -56.96%4.63M | 6.41%50.65M | 10.15%23.54M |
-Change in other current assets | 167.47%6.08M | 12.05%13.99M | -24.67%6.39M | -1.21%29.17M | -40.17%5.93M | -63.21%2.27M | 80.50%12.49M | 29.95%8.48M | -6.01%29.53M | 121.68%9.91M |
-Change in other current liabilities | 14.12%-9.4M | -27.64%-10.41M | -29.65%-12.74M | -74.68%-36.89M | -21.86%-7.96M | -235.93%-10.95M | 9.50%-8.16M | -324.03%-9.83M | 28.36%-21.12M | -113.65%-6.53M |
-Change in other working capital | -35.93%-24.51M | -75.46%-10.01M | 40.73%14.21M | -63.79%28.75M | 11.97%42.38M | -750.78%-18.03M | -132.36%-5.7M | -52.23%10.1M | -16.57%79.39M | -28.18%37.85M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 79.17%159.54M | 53.94%117.83M | 56.76%127.09M | 28.48%350.97M | 15.95%104.31M | 48.25%89.05M | 87.06%76.54M | -1.41%81.07M | 14.43%273.17M | -5.48%89.97M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -3,694.60%-569.38M | 369.53%213.16M | 24.90%-74.13M | -4.73%-334.77M | -145.49%-266.45M | 57.26%-15.01M | 137.53%45.4M | -79.36%-98.71M | -78.07%-319.66M | -1,007.07%-108.54M |
Capital expenditure reported | -33.65%-23.65M | -30.16%-21.44M | -43.06%-21.63M | -49.67%-66.37M | -31.47%-17.08M | -54.94%-17.69M | -61.36%-16.47M | -55.54%-15.12M | -33.82%-44.35M | -73.24%-13M |
Net PPE purchase and sale | -2.67%-11.13M | 24.63%-8.2M | -77.70%-5.88M | 9.91%-33.72M | -43.78%-8.69M | 17.31%-10.84M | -30.57%-10.88M | 66.70%-3.31M | -30.29%-37.43M | 46.66%-6.04M |
Net intangibles purchase and sale | ---- | ---- | ---- | 98.36%-164K | ---- | ---- | ---- | ---- | ---10M | --0 |
Net business purchase and sale | ---- | ---- | ---- | -4,476.32%-144.15M | -11,252.32%-141.9M | ---- | ---- | ---- | 84.18%-3.15M | ---1.25M |
Net investment purchase and sale | -3,462.86%-530.66M | 231.09%240.87M | 41.93%-46.62M | 59.79%-90.36M | -11.74%-98.61M | 276.77%15.78M | 178.92%72.75M | -126.94%-80.28M | -129.95%-224.74M | -1,077.95%-88.25M |
Net other investing changes | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -3,694.60%-569.38M | 369.53%213.16M | 24.90%-74.13M | -4.73%-334.77M | -145.49%-266.45M | 57.26%-15.01M | 137.53%45.4M | -79.36%-98.71M | -78.07%-319.66M | -1,007.07%-108.54M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 17.74%11.67M | 98.28%20.61M | 10.93%11.16M | 398.26%37.01M | -22.76%6.65M | 26.64%9.92M | 169.81%10.39M | 71.05%10.06M | 114.43%7.43M | 47.53%8.61M |
Net issuance payments of debt | ---- | ---- | ---- | 99.98%-13K | ---- | ---- | ---- | ---- | 9.05%-81.43M | --0 |
Proceeds from stock option exercised by employees | 19.30%15.97M | 90.29%25.3M | 77.21%19.94M | 19.65%47.74M | -3.68%9.8M | 33.59%13.38M | 69.44%13.3M | -5.05%11.25M | -14.22%39.9M | -17.82%10.18M |
Net other financing activities | -23.75%-4.29M | -61.71%-4.7M | -633.56%-8.79M | -121.88%-10.71M | -99.94%-3.14M | -105.95%-3.47M | 14.84%-2.9M | 72.49%-1.2M | 679.10%48.96M | -161.77%-1.57M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 17.74%11.67M | 98.28%20.61M | 10.93%11.16M | 398.26%37.01M | -22.76%6.65M | 26.64%9.92M | 169.81%10.39M | 71.05%10.06M | 114.43%7.43M | 47.53%8.61M |
Net cash flow | ||||||||||
Beginning cash position | 74.19%801.93M | 37.63%451.85M | 17.32%392.04M | -12.07%334.18M | 60.96%538.7M | 49.14%460.37M | -20.21%328.31M | -12.07%334.18M | -0.29%380.04M | 14.87%334.69M |
Current changes in cash | -574.25%-398.16M | 165.69%351.59M | 945.25%64.11M | 236.26%53.22M | -1,460.34%-155.49M | 156.09%83.96M | 239.38%132.33M | -122.94%-7.59M | -603.88%-39.06M | -110.92%-9.97M |
Effect of exchange rate changes | 283.85%10.35M | -450.73%-1.51M | -350.06%-4.31M | 168.26%4.65M | -6.58%8.83M | 17.09%-5.63M | 96.50%-274K | 204.43%1.72M | 23.14%-6.81M | 472.86%9.45M |
End cash Position | -23.13%414.11M | 74.19%801.93M | 37.63%451.85M | 17.32%392.04M | 17.32%392.04M | 60.96%538.7M | 49.14%460.37M | -20.21%328.31M | -12.07%334.18M | -12.07%334.18M |
Free cash flow | 106.19%124.77M | 79.27%88.19M | 58.96%99.57M | 38.21%250.72M | 10.50%78.38M | 70.30%60.51M | 297.37%49.19M | 0.12%62.64M | 2.57%181.4M | -7.11%70.93M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |